139 related articles for article (PubMed ID: 38040333)
21. Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre.
Fehlmann A; Benkortbi K; Rosseel G; Meyer-Hamme U; Tille JC; Sloan-Bena F; Paoloni-Giacobino A; Rougemont AL; Bodmer A; Botsikas D; Mathevet P; Petignat P; Undurraga Malinverno M
Swiss Med Wkly; 2021 Feb; 151():w20406. PubMed ID: 33578430
[TBL] [Abstract][Full Text] [Related]
22. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
[TBL] [Abstract][Full Text] [Related]
23. Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.
Buza N; Hui P
Mod Pathol; 2021 Sep; 34(9):1658-1672. PubMed ID: 34088998
[TBL] [Abstract][Full Text] [Related]
24. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
25. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
[TBL] [Abstract][Full Text] [Related]
26. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
28. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
29. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
Braga A; Campos V; Filho JR; Lin LH; Sun SY; de Souza CB; da Silva RCAF; Leal EAS; Silveira E; Maestá I; Madi JM; Uberti EH; Viggiano M; Elias KM; Horowitz N; Berkowitz RS
Gynecol Oncol; 2018 Feb; 148(2):239-246. PubMed ID: 29248195
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
31. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
[TBL] [Abstract][Full Text] [Related]
32. Gestational Trophoblastic Disease: Contemporary Diagnostic Approach.
Buza N
Surg Pathol Clin; 2022 Jun; 15(2):197-218. PubMed ID: 35715158
[TBL] [Abstract][Full Text] [Related]
33. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
Huang SC; Hsieh CY; Ouyang PC
J Formos Med Assoc; 1991 Jan; 90(1):53-8. PubMed ID: 1679110
[TBL] [Abstract][Full Text] [Related]
34. Invasive mole with lung metastasis after an abdominal complete hydatidiform mole treatment.
Suzuki S; Takahashi K; Obayashi S; Kitazawa M; Kuroda H; Fukasawa I
J Obstet Gynaecol Res; 2021 Jan; 47(1):420-424. PubMed ID: 33078868
[TBL] [Abstract][Full Text] [Related]
35. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
37. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
38. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
[TBL] [Abstract][Full Text] [Related]
39. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
[TBL] [Abstract][Full Text] [Related]
40. Gestational trophoblastic neoplasia: does centralization of care impact clinical management?
Mitric C; Yang K; Bhat G; Lheureux S; Laframboise S; Li X; Bouchard-Fortier G
Int J Gynecol Cancer; 2023 Nov; 33(11):1724-1732. PubMed ID: 37723102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
